Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Emory University
NRG Oncology
Wake Forest University Health Sciences
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Emory University
Ohio State University Comprehensive Cancer Center
National Medical Research Radiological Centre of the Ministry of Health of Russia
Brigham and Women's Hospital
Lithuanian University of Health Sciences
NRG Oncology
University of California, San Diego
University of Nebraska
M.D. Anderson Cancer Center
Eye & ENT Hospital of Fudan University
Saglik Bilimleri Universitesi
University Hospital, Strasbourg, France